Clinical trial
Cell-free DNA Promoter Hypermethylation in Plasma From Patients With Pancreatic Adenocarcinoma, Compared to Patients With Pancreatitis and Pancreatitis and Patients Screened for, But Not Having Pancreatic Adenocarcinoma."
NCT02079363 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cell-free DNA Promoter Hypermethylation in Plasma From Patients With Pancreatic Adenocarcinoma, Compared to Patients With Pancreatitis and Pancreatitis and Patients Screened for, But Not Having Pancreatic Adenocarcinoma."
- Lead sponsor
- Aalborg University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2013
- Completion date
- January 31, 2018
- Enrollment
- 330 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.